Skopos Bio

Skopos Bio is an Australian biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.

Health and bio

Skopos Bio raised $12M in a Seed round announced September 30, 2026, according to startupresearcher.com. Investors in that round: Tenmile, Tin Alley Ventures, Yosemite.

Raise history

1. September 30, 2026
   Seed · $12M
   TTenmile, TTin Alley Ventures, YYosemite
   Source: startupresearcher.com
2. September 2, 2026
   Website created

Investors

• TTenmile
• TTin Alley Ventures
• YYosemite

Related bio health companies

• SSunfox$7M · Oct 7, 2026
• AAlteogen$150M · Oct 6, 2026
• SSynvareOct 6, 2026
• SSuperMush$3M · Oct 6, 2026
• RRougeTx$58M · Oct 6, 2026
• AArcheon Medical$9M · Oct 6, 2026
• KKymaThera$80M · Oct 6, 2026
• AArboretum$30M · Oct 6, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/skopos-bio.